Clinical Trial Literacy: Empowering Nurses to Educate Hispanic Patients

Continuing Education Information:
Registered Nursing Credit Designation
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under provider number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.

Method of Participation
Participants must view the program, provide their contact information and license number, complete the post-assessment with a score of 70% or higher, and complete the activity evaluation in order to obtain CE credit. After completing this process, you will receive your certificate by email.

Continuing education credit is provided free of charge.

Target Audience:
This activity is intended for nurses and other healthcare professionals involved in the care of patients with cancer.

Learning Objectives:
After completing this activity, the participant should be better able to:

Summarize the brief evolution of research in the United States and its impact on current clinical practice
Describe the phases of a clinical trial and explain their significance in advancing medical treatments and benefiting the broader population
Identify key barriers to clinical trial participation, particularly among Hispanic patients
Demonstrate effective communication techniques for educating patients about clinical trials
Apply culturally sensitive strategies to address misconceptions and build patient trust
Explain how LLS Clinical Trial Support Center can help you and your patients

Faculty:
Jessica MacIntyre, DNP, MBA, APRN, AOCNP
President, Oncology Nursing Society
Assistant Vice President, Advanced Practice Providers
University of Miami/Sylvester Comprehensive Cancer Center
Miami, FL

Christopher Otero, BSc, MSN, AGNP-C
APP Team Manager
Oncology Clinical Research/Oncology Care Clinic (OCC)
University of Miami/Sylvester Comprehensive Cancer Center
Miami, FL

Leah Szumita, MS, RN, CCRN, ACNS-BC
Senior Director
Clinical Trial Support Center
The Leukemia & Lymphoma Society
Washington, DC

Providers:
This activity is provided by The Leukemia & Lymphoma Society (LLS) in collaboration with the National Association of Hispanic Nurses (NAHN) and The Oncology Nursing Society (ONS).

Disclaimer:
The information provided in this activity is for educational purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition.

Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Provider: The Leukemia & Lymphoma Society
Estimated time to complete activity: 1.0 hour
Date of initial release: June 24, 2025
Date of expiration: December 18, 2026


Continuing Education Information: Registered Nursing Credit Designation Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under provider number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing. Method of Participation Participants must view the program, provide their contact information and license number, complete the post-assessment with a score of 70% or higher, and complete the activity evaluation in order to obtain CE credit. After completing this process, you will receive your certificate by email. Continuing education credit is provided free of charge. Target Audience: This activity is intended for nurses and other healthcare professionals involved in the care of patients with cancer. Learning Objectives: After completing this activity, the participant should be better able to: Summarize the brief evolution of research in the United States and its impact on current clinical practice Describe the phases of a clinical trial and explain their significance in advancing medical treatments and benefiting the broader population Identify key barriers to clinical trial participation, particularly among Hispanic patients Demonstrate effective communication techniques for educating patients about clinical trials Apply culturally sensitive strategies to address misconceptions and build patient trust Explain how LLS Clinical Trial Support Center can help you and your patients Faculty: Jessica MacIntyre, DNP, MBA, APRN, AOCNP President, Oncology Nursing Society Assistant Vice President, Advanced Practice Providers University of Miami/Sylvester Comprehensive Cancer Center Miami, FL Christopher Otero, BSc, MSN, AGNP-C APP Team Manager Oncology Clinical Research/Oncology Care Clinic (OCC) University of Miami/Sylvester Comprehensive Cancer Center Miami, FL Leah Szumita, MS, RN, CCRN, ACNS-BC Senior Director Clinical Trial Support Center The Leukemia & Lymphoma Society Washington, DC Providers: This activity is provided by The Leukemia & Lymphoma Society (LLS) in collaboration with the National Association of Hispanic Nurses (NAHN) and The Oncology Nursing Society (ONS). Disclaimer: The information provided in this activity is for educational purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred. Provider: The Leukemia & Lymphoma Society Estimated time to complete activity: 1.0 hour Date of initial release: June 24, 2025 Date of expiration: December 18, 2026